Deferasirox | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Deferasirox
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Zhejiang Hengkang Deferasirox

Contact Supplier

dmfs-not-supported-m-2025-05-19

PharmaCompass Sponsored Ads

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Deferasirox

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

83 API Suppliers, 24 USDMF, 12 CEP/COS, 1 JDMF, 23 EU WC, 16 KDMF, 17 NDC API, 51 Listed Suppliers, $ API Reference Price

83 API Suppliers
24 USDMF
12 CEP/COS
1 JDMF
23 EU WC
16 KDMF
17 NDC API
51 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

33 Intermediate Suppliers

33 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

383 FDF Dossiers, 111 FDA Orange Book, 46 Europe, 33 Canada, 144 Australia, 7 South Africa, 42 Listed Dossiers

383 FDF Dossiers
111 FDA Orange Book
46 Europe
33 Canada
144 Australia
7 South Africa
42 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GRANULE;ORAL - 180MG, GRANULE;ORAL - 360MG, GRANULE;ORAL - 90MG

GRANULE;ORAL - 180MG
GRANULE;ORAL - 360MG
GRANULE;ORAL - 90MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 4 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 17 Kerry, 9 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

1 SPI Pharma
1 DKSH
3 Faran Shimi Pharmaceutical
3 Boai NKY Pharmaceuticals Ltd
3 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
6 BASF
4 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
17 Kerry
9 Microlex e.U
1 Nanjing Bold Chemical
1 Pharmatrans-Sanaq
3 Pluviaendo
2 Prachin Chemical
7 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
9 Sigachi Industries
2 Silverline Chemicals
1 Ulanqab Kema New Material
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Fillers, Diluents & Binders, 13 Direct Compression, 13 Lubricants & Glidants, 12 Granulation, 11 Thickeners and Stabilizers, 9 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 4 Taste Masking, 4 Emulsifying Agents, 4 Controlled & Modified Release, 4 Coating Systems & Additives, 2 Parenteral, 2 Film Formers & Plasticizers, 2 API Stability Enhancers, 2 Solubilizers, 2 Topical, 2 Chewable & Orodispersible Aids, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

39 Fillers, Diluents & Binders
13 Direct Compression
13 Lubricants & Glidants
12 Granulation
11 Thickeners and Stabilizers
9 Co-Processed Excipients
4 Disintegrants & Superdisintegrants
4 Taste Masking
4 Emulsifying Agents
4 Controlled & Modified Release
4 Coating Systems & Additives
2 Parenteral
2 Film Formers & Plasticizers
2 API Stability Enhancers
2 Solubilizers
2 Topical
2 Chewable & Orodispersible Aids
1 Surfactant & Foaming Agents
1 Rheology Modifiers

DIGITAL CONTENT

59 News #PharmaBuzz

59 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 42 Regulatory FDF Prices, 9 Annual Reports

3 US Medicaid Prescriptions
42 Regulatory FDF Prices
9 Annual Reports

MARKET PLACE

10 APIs, 3 FDF Dossiers

10 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 6 Health Canada Patents

3 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

12 Others

12 Others

$ API Ref.Price (USD/KG) : 395 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

33 All

01 6APOTEX INC

02 3AURO PHARMA INC

03 6NOVARTIS PHARMACEUTICALS CANADA INC

04 6PHARMASCIENCE INC

05 6SANDOZ CANADA INCORPORATED

06 6TARO PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

33 All

01 33DEFERASIROX

filter Dosage Form Reset all filters

33 All

01 18TABLET

02 15TABLET FOR SUSPENSION

filter Brand Name Reset all filters

33 All

01 3APO-DEFERASIROX

02 3APO-DEFERASIROX (TYPE J)

03 3AURO-DEFERASIROX (TYPE J)

04 3EXJADE

05 3JADENU

06 3PMS-DEFERASIROX

07 3PMS-DEFERASIROX (TYPE J)

08 3SANDOZ DEFERASIROX

09 3SANDOZ DEFERASIROX (TYPE J)

10 3TARO-DEFERASIROX

11 3TARO-DEFERASIROX (TYPE J)

Synnat Deferasirox

List of Suppliers

Product Main Page

01

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : APO-DEFERASIROX

Dosage Form : TABLET FOR SUSPENSION

Dosage Strength : 125MG

Packaging : 30

Approval Date :

Application Number : 2461544

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : APO-DEFERASIROX

Dosage Form : TABLET FOR SUSPENSION

Dosage Strength : 250MG

Packaging : 30

Approval Date :

Application Number : 2461552

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

STLE Annual Meeting

Not Confirmed

APOTEX INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : APO-DEFERASIROX

Dosage Form : TABLET FOR SUSPENSION

Dosage Strength : 500MG

Packaging : 30

Approval Date :

Application Number : 2461560

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

NOVARTIS PHARMACEUTICALS CANADA INC

STLE Annual Meeting

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET FOR SUSPENSION

Dosage Strength : 125MG

Packaging : 28

Approval Date :

Application Number : 2287420

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

NOVARTIS PHARMACEUTICALS CANADA INC

STLE Annual Meeting

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET FOR SUSPENSION

Dosage Strength : 250MG

Packaging : 28

Approval Date :

Application Number : 2287439

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

NOVARTIS PHARMACEUTICALS CANADA INC

STLE Annual Meeting

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET FOR SUSPENSION

Dosage Strength : 500MG

Packaging : 28

Approval Date :

Application Number : 2287447

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

NOVARTIS PHARMACEUTICALS CANADA INC

STLE Annual Meeting

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : JADENU

Dosage Form : TABLET

Dosage Strength : 90MG

Packaging : 30

Approval Date :

Application Number : 2452219

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

SANDOZ CANADA INCORPORATED

STLE Annual Meeting

Not Confirmed

SANDOZ CANADA INCORPORATED

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : SANDOZ DEFERASIROX (TYPE J)

Dosage Form : TABLET

Dosage Strength : 90MG

Packaging :

Approval Date :

Application Number : 2489899

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

09

SANDOZ CANADA INCORPORATED

STLE Annual Meeting

Not Confirmed

SANDOZ CANADA INCORPORATED

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : SANDOZ DEFERASIROX (TYPE J)

Dosage Form : TABLET

Dosage Strength : 180MG

Packaging :

Approval Date :

Application Number : 2489902

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

10

SANDOZ CANADA INCORPORATED

STLE Annual Meeting

Not Confirmed

SANDOZ CANADA INCORPORATED

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DEFERASIROX

Brand Name : SANDOZ DEFERASIROX (TYPE J)

Dosage Form : TABLET

Dosage Strength : 360MG

Packaging :

Approval Date :

Application Number : 2489910

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!